Paper29356
Preparation of human leukocyte interferon for clinical use.
Cantell K and 1 other. Tex Rep Biol Med, 1977. Cited by 89 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Preparation of human leukocyte interferon for clinical use. Papers, record 29356. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29356
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Interferons | Major topic |
| Leukocytes | Major topic |
| Chemical Precipitation | |
| Cold Temperature | |
| Ethanol | |
| Humans | |
| Hydrogen-Ion Concentration | |
| Thiocyanates |
Source PubMed
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 89 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 6,477,131 | Purification of human leukocyte interferon alpha by carboxymethyl controlled pore glass bead chromatography. | Arch Virol | 1984 | https://conductscience.org/library/papers/6477131 | PubMed |
| 6,301,405 | Characteristics of spontaneously produced and of virus-induced human LuKII cell interferons. | Arch Virol | 1983 | https://conductscience.org/library/papers/6301405 | PubMed |
| 6,222,855 | Humoral immune response in aged humans: suppressor effect of monocytes on spontaneous plaque forming cell generation. | Clin Exp Immunol | 1983 | https://conductscience.org/library/papers/6222855 | PubMed |
| 6,182,105 | Use of an anti-human leukocyte interferon monoclonal antibody for the purification and radioimmunoassay of human alpha interferon. | Infect Immun | 1982 | https://conductscience.org/library/papers/6182105 | PubMed |
| 6,176,663 | Interferon inhibits the generation of allospecific suppressor T lymphocytes. | J Exp Med | 1982 | https://conductscience.org/library/papers/6176663 | PubMed |
| 6,165,322 | Replacement of animal serum proteins by human albumin for growth and interferon production by Namalva cells. | Antimicrob Agents Chemother | 1980 | https://conductscience.org/library/papers/6165322 | PubMed |
| 6,155,349 | Inhibition by interferon of Sendai virus cytolysis. | Infect Immun | 1980 | https://conductscience.org/library/papers/6155349 | PubMed |
| 6,084,313 | Interferons, a group of multiple lymphokines. | Springer Semin Immunopathol | 1984 | https://conductscience.org/library/papers/6084313 | PubMed |
| 3,925,974 | The effects of alpha and gamma interferons on human lung cancer cells grown in vitro or as xenografts in nude mice. | Br J Cancer | 1985 | https://conductscience.org/library/papers/3925974 | PubMed |
| 2,425,443 | Interferons: current status and future directions of this prototypic biological. | Springer Semin Immunopathol | 1986 | https://conductscience.org/library/papers/2425443 | PubMed |
| 40,881 | Large-scale production and physicochemical characterization of human immune interferon. | Infect Immun | 1979 | https://conductscience.org/library/papers/40881 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/29356
GET https://conductscience.org/api/papers/v1/29356/authors